Long-term mortality after coronary revascularization in nondiabetic patients with multivessel disease

M Chang, JM Ahn, CW Lee, R Cavalcante… - Journal of the American …, 2016 - jacc.org
Background: In diabetic patients with multivessel coronary artery disease (CAD), the survival
difference between coronary artery bypass graft (CABG) surgery and percutaneous coronary …

[HTML][HTML] Strategies for multivessel revascularization in patients with diabetes

ME Farkouh, M Domanski, LA Sleeper… - New England journal …, 2012 - Mass Medical Soc
Background In some randomized trials comparing revascularization strategies for patients
with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than …

A 3-year clinical outcome after percutaneous coronary intervention using sirolimus-eluting stent and off-pump coronary artery bypass grafting for the treatment of …

K Yamagata, Y Kataoka, N Kokubu, Y Kasahara… - Circulation …, 2010 - jstage.jst.go.jp
Background: There are few data to compare the long-term efficacy of sirolimus-eluting stent
(SES) and off-pump coronary artery bypass grafting (OPCAB) for diabetic patients with …

Long-term survival after surgical or percutaneous revascularization in patients with diabetes and multivessel coronary disease

DY Tam, C Dharma, R Rocha, ME Farkouh… - Journal of the American …, 2020 - jacc.org
Background There remains a paucity of real-world observational evidence comparing
percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) in …

Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study

ME Farkouh, M Domanski, GD Dangas… - Journal of the American …, 2019 - jacc.org
Abstract Background: The FREEDOM (Future Revascularization Evaluation in Patients with
Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for …

Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass …

LJ Kim, SB King, K Kent, MM Brooks, KE Kip… - JACC: Cardiovascular …, 2009 - jacc.org
Objectives: We evaluated demographic, clinical, and angiographic factors influencing the
selection of coronary artery bypass graft (CABG) surgery versus percutaneous coronary …

Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization

YG Kim, DW Park, WS Lee, GM Park, BJ Sun… - The American journal of …, 2012 - Elsevier
Diabetes mellitus is a major risk factor for coronary artery disease (CAD) and for diffuse and
progressive atherosclerosis. We evaluated the outcomes of drug-eluting stent (DES) …

Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary …

EA Magnuson, ME Farkouh, V Fuster, K Wang… - Circulation, 2013 - Am Heart Assoc
Background—Studies from the balloon angioplasty and bare metal stent eras have
demonstrated that coronary artery bypass grafting (CABG) is cost-effective compared with …

Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials

S Verma, ME Farkouh, B Yanagawa… - The lancet Diabetes & …, 2013 - thelancet.com
Background The choice between coronary artery bypass surgery (CABG) and percutaneous
coronary intervention (PCI) for revascularisation in patients with diabetes and multivessel …

Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDia (Coronary …

A Kapur, RJ Hall, IS Malik, AC Qureshi, J Butts… - Journal of the American …, 2010 - jacc.org
Objectives: The purpose of this study was to compare the safety and efficacy of
percutaneous coronary intervention (PCI) with stenting against coronary artery bypass …